May. 26 at 11:39 AM
$BCTX
Sixth consecutive positive recommendation from the DSMB.
At this point, I'm wondering what do we need to see the SP rising consistently.
"Following its review, the DSMB raised no safety concerns and recommended that the study continue without modifications. DSMB meetings occur quarterly in accordance with the study protocol. BriaCell’s ongoing pivotal Phase 3 study is being conducted under Fast Track designation granted by the US Food and Drug Administration (FDA), reflecting the significant unmet medical need in metastatic breast cancer."
https://finviz.com/news/356858/briacell-receives-positive-recommendation-from-data-safety-monitoring-board-dsmb-for-phase-3-study-in-metastatic-breast-cancer
